Also found in: Wikipedia.
CODITCode-Division Testbed
CODITCompartmentalization of Decay in Trees
CODITCompact Diagnostic Test (various locations)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Aimmune will retain all current and future pipeline assets developed with the CODIT approach, including AR101, the company's investigational oral biologic desensitisation therapy for peanut allergy, which is currently in Phase 3 clinical development.
Research has shown that 'tree paints,' while popular in the past, actually inhibit the CODIT process and act to harbor insects and decay.
2) What CODIT wall is responsible for preventing decay from spreading into new wood produced after injury?
The Company's first development program to use CODIT is AR101, an investigational biologic drug for use in oral immunotherapy as a treatment to reduce the frequency and severity of allergic reactions following exposure to peanut.
Sallami, "An improved fuzzy logic control of irrigation station," in Proceedings of the International Conference on Control, Decision and Information Technologies (CoDIT '17), Barcelona, Spain, April 2017.
Aimmune's first investigational biologic product using CODIT, AR101 for the treatment of peanut allergy, has received the FDA's Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age.
Yalaoui, "Bi objective artificial immune algorithms to the joint production scheduling and maintenance planning," in Proceedings of the International Conference on Control, Decision and Information Technologies (CoDIT '13), pp.
According to the contract, Aimmune will continue to own all existing and future pipeline assets developed with the CODIT approach.
With development and commercialization success of AR101, the market should begin to value the company's characterized oral delivery immunotherapy CODIT platform and the opportunities that could be provided by egg and walnut allergy therapies, he contended.
Jaafar, "Magnetic hysteresis modeling and numerical simulation for ferromagnetic materials," in Proceedings of 2013 International Conference on Control, Decision and Information Technologies, CoDIT 2013, pp.
The primary objective of the trial is to assess whether dupilumab as adjunct to AR101 in a Characterized Oral Desensitization ImmunoTherapy (CODIT) regimen, compared to placebo with AR101 in a CODIT regimen, improves desensitisation at the completion of up-dosing, defined as an increase in the proportion of participants who pass a double-blind, placebo-controlled food challenge (DBPCFC) with a single-highest tolerated dose of 1,000 mg of peanut protein (equivalent to a cumulative amount of 2,044 mg of peanut protein).
Aimmune expects to use the net proceeds from this offering to fund its ongoing clinical development of AR101, an investigational biologic for the treatment of patients with peanut allergy; regulatory activities related to the potential filing of a biologics license application and a marketing authorisation application for AR101; preparation for potential commercialization of AR101; research and development of additional CODIT product candidates; and for general corporate purposes.